AVIR
Atea Pharmaceuticals, Inc.
5.00
1 x 3.54
2 x 6.25
bid
ask
+
0.22
4.56%
10:17 AM
timesize
| Ytd | 40.00% | |
| 1y | 37.69% |
4.78
day range
5.02
2.78
52 week range
6.45
| Open | 4.89 | Prev Close | 4.78 | Low | 4.78 | High | 5.02 | Mkt Cap | 399.98M |
| Vol | 38.55K | Avg Vol | 328.91K | EPS | -2.11 | P/E | N/A | Forward P/E | -2.12 |
| Beta | 0.17 | Short Ratio | 14.25 | Inst. Own | 71.14% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 4.76 | 200-d Avg | 4.16 | 1yr Est | 7.40 |
| Income Statement | |||
| Operating Expenses | 48.01M | ||
| Research and Development Expense | 41.13M | ||
| Selling, General and Administrative Expense | 6.87M | ||
| Operating Income | -48.01M | ||
| Income Tax Expense | 50.00K | ||
| Net Income | -45.44M | ||
| Net Income Common Stock | -45.44M | ||
| Net Income Common Stock (USD) | -45.44M | ||
| Consolidated Income | -45.44M | ||
| Earnings per Basic Share | -0.57 | ||
| Earnings per Basic Share (USD) | -0.57 | ||
| Earnings per Diluted Share | -0.57 | ||
| Earning Before Interest & Taxes (EBIT) | -45.39M | ||
| Earning Before Interest & Taxes (USD) | -45.39M | ||
| Weighted Average Shares | 79.20M | ||
| Weighted Average Shares Diluted | 79.20M | ||
| Balance Sheet | |||
| Cash and Equivalents | 79.32M | ||
| Cash and Equivalents (USD) | 79.32M | ||
| Investments | 176.69M | ||
| Investments Current | 176.69M | ||
| Current Assets | 263.20M | ||
| Property, Plant & Equipment Net | 831.00K | ||
| Total Assets | 267.08M | ||
| Debt Current | 634.00K | ||
| Total Debt | 634.00K | ||
| Current Liabilities | 33.37M | ||
| Total Liabilities | 33.37M | ||
| Accumulated Retained Earnings (Deficit) | -568.01M | ||
| Accumulated Other Comprehensive Income | -97.00K | ||
| Shareholders Equity | 233.71M | ||
| Shareholders Equity (USD) | 233.71M | ||
| Assets Non-Current | 3.88M | ||
| Total Debt (USD) | 634.00K | ||
| Trade and Non-Trade Payables | 9.45M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 104.00K | ||
| Net Cash Flow from Financing | 257.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -16.40M | ||
| Issuance (Purchase) of Equity Shares | 257.00K | ||
| Net Cash Flow from Investing | 29.74M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 29.74M | ||
| Net Cash Flow from Operations | -46.39M | ||
| Share Based Compensation | 3.73M | ||